Evidence map›Paper›PMID 42588479›Full record

SynthesisMolecules (Basel, Switzerland)2026

Antileishmanial Activity of Bioactive Compounds Obtained from

Jeison Alfonso Yaima-Yate, Catalina Lapuente-Chala, Daniel Alfonso Urrea-Montes, Ángel Enrique Céspedes-Rubio

Abstract readSystematic Review
In one paragraph

Synthesis in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jeison Alfonso Yaima-YateIMPRONTA Research Group, Faculty of Veterinary Medicine and Animal Science, Universidad Cooperativa de Colombia, Ibague 730006, Colombia.ORCID 0000-0001-8635-3306
Catalina Lapuente-ChalaIMPRONTA Research Group, Faculty of Veterinary Medicine and Animal Science, Universidad Cooperativa de Colombia, Ibague 730006, Colombia.ORCID 0000-0001-5672-9376
Daniel Alfonso Urrea-MontesTropical Parasitology Research Laboratory (LIPT), Faculty of Sciences, Department of Biology, Universidad del Tolima, Ibague 730006, Colombia.ORCID 0000-0003-3846-7143
Ángel Enrique Céspedes-RubioNeurodegenerative Diseases Research Group (END), Department of Animal Health, Universidad del Tolima, Ibague 730006, Colombia.ORCID 0000-0003-0803-5008

Funding

Bill & Melinda Gates Foundation INV-003799Universidad Cooperativa de Colombia INV3799
6 · The paper itself

Abstract

Leishmaniasis, a poorly studied tropical disease, has major therapeutic limitations, driving the search for safer, effective treatments. This review assessed scientific evidence on the antileishmanial activity of extracts, fractions, and bioactive compounds from

Indexed as

Antiprotozoal AgentsAzadirachtaLeishmaniaLeishmaniasisPhytochemicalsPlant ExtractsAnimalsHumansMiceAntiprotozoal AgentsPhytochemicalsPlant ExtractsantiparasiticbiofunctionalLeishmaniaphytopharmaceuticalszoonosis

Identifiers

PMID42588479
PMCPMC13468044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.